Telaglenastat (CB-839)

telaglenastat · Calithera Biosciences

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Telaglenastat (CB-839), covering 2024-05-14 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: TEPH: Telaglenastat Efficacy in Pulmonary Hypertension [Phase 1, Phase 2]